Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Repertaxin

Repertaxin

Repertaxin structure

Repertaxin 

structure
  • CAS No:

    266359-83-5

  • Formula:

    C14H21NO3S

  • Chemical Name:

    Repertaxin

  • Synonyms:

    Benzeneacetamide,α-methyl-4-(2-methylpropyl)-N-(methylsulfonyl)-,(αR)-;(αR)-α-Methyl-4-(2-methylpropyl)-N-(methylsulfonyl)benzeneacetamide;Reparixin;Repertaxin;DF 1681Y;(R)-(-)-N-2-[(4-Isobutylphenyl)propionyl]methanesulfonamide;(2R)-2-[4-(2-Methylpropyl)phenyl]-N-methylsulfonylpropanamide

Description

Reparixin is a monoterpenoid.|Reparixin has been used in trials studying the treatment and prevention of Breast Cancer, Metastatic Breast Cancer, Pancreatectomy for Chronic Pancreatitis, Islet Transplantation in Diabetes Mellitus Type 1, and Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus.|Reparixin is an orally available inhibitor of CXC chemokine receptor types 1 (CXCR1) and 2 (CXCR2), with potential antineoplastic activity. Upon administration, reparixin allosterically binds to CXCR1 and prevents CXCR1 activation by its ligand interleukin 8 (IL-8 or CXCL8). This may cause cancer stem cell (CSC) apoptosis and may inhibit tumor cell progression and metastasis. CXCR1, overexpressed on CSCs, plays a key role in CSC survival and the ability of CSC to self-renew; it is also linked to tumor resistance to chemotherapy. Inhibition of the IL-8/CXCR1 interaction also potentiates the cytotoxic effect of chemotherapeutic agents. In addition, reparixin inhibits CXCR2 activation and may reduce both neutrophil recruitment and vascular permeability during inflammation or injury.

Repertaxin Basic Attributes

283.39

283.39

U604E1NB3K

DTXSID6046509

C66515

Characteristics

1.137±0.06 g/cm3

103-105 °C

4.28±0.40

Safety Information

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Drug Information

Prevention of graft rejection

(R)-2-(4-isobutylphenyl)propionylmethanesulfonamide

Repertaxin Use and Manufacturing

Uses

Prevention of delayed graft function in solid organ transplant (CXCL8 inhibitor).

Human drugs -> Rare disease (orphan)|Human Drugs -> EU pediatric investigation plans

Computed Properties

Molecular Weight:283.39
XLogP3:2.9
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:5
Exact Mass:283.12421471
Monoisotopic Mass:283.12421471
Topological Polar Surface Area:71.6
Heavy Atom Count:19
Complexity:389
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.